shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
13 November 2020Americas

FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent

The US Food and Drug Administration (FDA) will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Big Pharma
5 November 2020   Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.
Americas
14 September 2021   The US Food and Drug Administration has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.

More on this story

Asia
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Big Pharma
5 November 2020   Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.
Americas
14 September 2021   The US Food and Drug Administration has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.

More on this story

Asia
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Big Pharma
5 November 2020   Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.
Americas
14 September 2021   The US Food and Drug Administration has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.